| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.72B | +8.3% |
| Cost of Revenue | $1.23B | +8.3% |
| Gross Profit | $1.49B | +8.3% |
| R&D Expense | $114.0M | +15.0% |
| SG&A Expense | $1.16B | -0.1% |
| Operating Income | $216.1M | +120.8% |
| Pre-tax Income | $177.2M | +116.3% |
| Income Tax | $130.2M | +284.1% |
| Net Income | $47.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.21B | +13.3% |
| Accounts Receivable | $429.6M | +18.3% |
| Inventory | $288.1M | +19.5% |
| Current Assets | $2.03B | +13.3% |
| Total Assets | $5.68B | +6.1% |
| Current Liabilities | $852.6M | -3.0% |
| Long-term Debt | $1.45B | +3.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $275.7M | -18.1% |
| Capital Expenditures | $45.3M | +34.0% |
| Investing Cash Flow | -$51.1M | +6.4% |
| Financing Cash Flow | -$170.9M | -64.8% |
| Free Cash Flow | $230.4M | -23.9% |
| +104.2% |
| EPS (Basic) | $0.28 | +104.3% |
| EPS (Diluted) | $0.28 | +104.3% |
| Stockholders' Equity |
| $3.11B |
| +5.8% |